Extracellular matrix glycoprotein (generic, not a single canonical molecule) (None (these are a group, not a distinct abbreviation))

The extracellular matrix glycoproteins in the gastrointestinal submucosa are a diverse class of proteins contributed primarily by mesenchymal cells. Major examples include *laminins*, *fibronectin*, *nidogen*, *elastin*, and *tenascin*, which work with collagens and proteoglycans to form the structural and functional scaffold of the intestinal wall[1][4]. These glycoproteins are involved in cell adhesion, migration, proliferation, differentiation, and crosstalk with surface receptors such as integrins. They play central roles in tissue architecture, wound healing, epithelial barrier function, and the response to injury or inflammation[1][4][5]. As a class, they are highly dynamic and subject to remodeling in disease states (e.g., inflammatory bowel disease, fibrosis), but cannot be defined as a single pharmacological or molecular target.

Other names

Glycoproteins of the intestinal extracellular matrixECM glycoproteins in gut submucosaintestinal submucosal glycoproteinsbasement membrane glycoproteins (but no one alias fits all these proteins)

Not applicable as a direct drug target (Some drugs may indirectly affect ECM glycoprotein activity, e.g., matrix metalloproteinase inhibitors which modulate ECM remodeling[1][4])